-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
ADC Therapeutics SA quarterly/annual Operating Income (Loss) history and growth rate from Q1 2023 to Q4 2024.
- ADC Therapeutics SA Operating Income (Loss) for the quarter ending December 31, 2024 was -$32.4M, a 18.9% increase year-over-year.
- ADC Therapeutics SA Operating Income (Loss) for the twelve months ending December 31, 2024 was -$131M, a 21.3% increase year-over-year.
- ADC Therapeutics SA annual Operating Income (Loss) for 2024 was -$131M, a 21.3% increase from 2023.
- ADC Therapeutics SA annual Operating Income (Loss) for 2023 was -$166M, a 34.6% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)